Filing Details
- Accession Number:
- 0001209191-20-036386
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-12 18:00:12
- Reporting Period:
- 2020-06-10
- Accepted Time:
- 2020-06-12 18:00:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1492426 | Horizon Therapeutics Public Ltd Co | HZNP | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1769107 | Jeff Kent | C/O Horizon Therapeutics Plc Connaught House, 1St Fl, 1 Burlington Rd Dublin L2 4 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2020-06-10 | 5,000 | $0.00 | 65,994 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2020-06-10 | 2,216 | $48.60 | 63,778 | No | 4 | F | Direct | |
Ordinary Shares | Disposition | 2020-06-10 | 2,785 | $48.05 | 60,993 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Restricted Stock Units (RSU) | Disposition | 2020-06-10 | 5,000 | $0.00 | 5,000 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
5,000 | No | 4 | M | Direct |
Footnotes
- Each RSU represents a contingent right to receive one ordinary share of the Issuer.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2020.
- On June 10, 2018, the reporting person was granted 15,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.